Resources
Filters
GLP-1s: Real-world insights from 10,000 users
GLP-1s: Real-world insights from 10,000 users
GLP-1s: Real-world insights from 10,000 users

GLP-1s: Real-world insights from 10,000 users
Evidation's direct-to-participant connection is reshaping real-world insights into weight management journeys and GLP-1 usage. Explore what's possible with interactive real-world data collected directly from 10,000+ people using GLP-1s.

Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
Leveraging Real-World Data: Insights into Depression from Surveys and Wearables

Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
A continuous, direct connection to an online community of engaged individuals willing to respond to surveys and connect their devices and apps, such as Apple Watches and Fitbits, presents opportunities to capture data longitudinally. These novel, layered datasets help accurately and comprehensively describe the real-world experiences with depression and psycho- and pharmacotherapy.

Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer

Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation announces the addition of a new Chief Commercial Officer, Phil Johnson, and board member, Ian Lennox.

A deeper understanding of epilepsy treatment use and need for support services
A deeper understanding of epilepsy treatment use and need for support services
A deeper understanding of epilepsy treatment use and need for support services

A deeper understanding of epilepsy treatment use and need for support services
Jazz Pharmaceuticals contacted our team to help develop and deploy a survey to better understand caregivers’ perspectives on the real-world implications of dependents’ use of Epidiolex and non-FDA-approved cannabinoid products.

Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Trialbee and Evidation partner to accelerate and diversify clinical research recruitment

Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Learn how Evidation and Trialbee's joint offering and shared commitment to inclusion and data transparency drives enrollment outcomes.

Quantifying migraine burden and frequency in day-to-day life
Quantifying migraine burden and frequency in day-to-day life
Quantifying migraine burden and frequency in day-to-day life

Quantifying migraine burden and frequency in day-to-day life
The prevalence and burden of headache disorders in real-world settings is relatively unstudied, leading to underdiagnosis and condition management challenges.

Rock Health shares findings from weight care survey with Evidation
Rock Health shares findings from weight care survey with Evidation
Rock Health shares findings from weight care survey with Evidation

Rock Health shares findings from weight care survey with Evidation
Evidation helped Rock Health conduct surveys that investigated experience and perceptions of a variety of weight care solutions. Read key highlights here.

Behavioral Engagement and Activation Model Study (BEAMS)
Behavioral Engagement and Activation Model Study (BEAMS)
John D Piette, Keni C S Lee, Hayden B Bosworth, Diana Isaacs, Christian J Cerrada, Raghu Kainkaryam, Jan Liska, Felix Lee, Adee Kennedy, David Kerr
Behavioral Engagement and Activation Model Study (BEAMS)
John D Piette, Keni C S Lee, Hayden B Bosworth, Diana Isaacs, Christian J Cerrada, Raghu Kainkaryam, Jan Liska, Felix Lee, Adee Kennedy, David Kerr

Behavioral Engagement and Activation Model Study (BEAMS)
Evidation and Sanofi partnered to look at Type 2 Diabetes patients with and without digital health technology (DHT) use to understand who might require more tailored support to adopt DHTs.
John D Piette, Keni C S Lee, Hayden B Bosworth, Diana Isaacs, Christian J Cerrada, Raghu Kainkaryam, Jan Liska, Felix Lee, Adee Kennedy, David Kerr

Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions

Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Evidation’s consumer app and research platform have been recognized by Frost & Sullivan for the value they provide to life science and healthcare organizations and individuals in everyday life

Evidation launches MigraineSmart on the Evidation app
Evidation launches MigraineSmart on the Evidation app
Evidation launches MigraineSmart on the Evidation app

Evidation launches MigraineSmart on the Evidation app
Evidation has officially launched MigraineSmart, a health engagement experience and symptom tracking program on the Evidation app that harnesses different forms of data to help individuals better understand and manage their migraines.

No results found. Try broadening your search for more results!